Chemistry — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Assort provides voice AI agents for healthcare that use deep patient interaction data to proactively guide patients through their care journey, orchestrating tasks from intake and scheduling to billing and care gap closure.
AI & Machine LearningDigital HealthHealthtech
Jeffery Liu(Founder)inJon Wang(Founder)inJeffery L.(Founder)inJeff Liu(Founder)inJonathan Wang(Founder)Jonathan Wang Jeffery Liu(Founder)
Co-investorsAlumni VenturesavraCoho DeeptechCold Start VenturesCollective LiquidityFelicis Ventures+19 more
Siemens Building X provides space and workplace management applications for facility owners, enabling workspace bookings, office navigation, and schedule coordination with real-time usage insights and environmental monitoring.
Enterprise SoftwarePropTech
Co-investorsClaremont Creek VenturesNavitas CapitalThe Westly GroupAbstract VenturesEmergence Capital PartnersM12 (Microsoft's Venture Fund)+1 more
Comprehensive provides AI-powered compensation analytics and benchmarking software for managing employee pay, equity, and pay equity analysis.
AI & Machine LearningHR TechSaaSSan Francisco, US
Roger Lee(Executive Officer, Director, Promoter)inTeddy Sherrill(Executive Officer, Director, Promoter)in
Co-investorsFloodgateInspired CapitalJude GomilaSoma Capital8VCAccess Industries+14 more
Datacurve develops research and data collection infrastructure for training AI systems.
AI & Machine LearningData & InfrastructureEnterprise SoftwareSan Francisco, US
Serena Ge(CEO)inCharley Lee(Founder)inSerena Ge Charley Lee(Founder)Victoria Wan(GTM)inJinjin Niu(GTM)tazik shahjahan(Talent Engineer)
Co-investorsAfore CapitalHomebrewNorthside VenturesPioneerY CombinatorAccomplice+9 more
Identity verification enabling companies to confirm their users' identities.
Charles Yeh(Founder)in
Co-investorsFelicis VenturesFirebolt Ventures Management Company, LlcFirst Round CapitalFounders FundIndex VenturesInsight Partners+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




























